Paliperidone palmitate-d4
Paliperidone palmitate-d4 (9-Hydroxyrisperidone palmitate-d4) is the deuterium labeled Paliperidone palmitate. Paliperidone palmitate is an orally effective competitive antagonist of dopamine D2 receptors and 5-hydroxytryptamine 2A (5-HT2A) receptors that can cross the blood-brain barrier. Paliperidone palmitate competitively inhibits the effects of dopamine and 5-hydroxytryptamine by binding to dopamine D2 receptors and 5-HT2A receptors, regulating the balance of the neurotransmitter system and thus exerting antipsychotic activity. Paliperidone palmitate is mainly used in the research field of schizophrenia[1][2][3].
Product Specifications
CAS Number
1794685-21-4
Product Name Alternative
9-Hydroxyrisperidone palmitate-d4
UNSPSC
12352005
Target
5-HT Receptor; Dopamine Receptor; Isotope-Labeled Compounds
Related Pathways
GPCR/G Protein; Neuronal Signaling; Others
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Smiles
FC1=CC=C(C(C2CCN(CC2)C([2H])([2H])C([2H])([2H])C3=C(C)N=C(C(CCC4)OC(CCCCCCCCCCCCCCC)=O)N4C3=O)=NO5)C5=C1
Molecular Formula
C39H53D4FN4O4
Molecular Weight
668.92
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
KIF11 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)
1000 mL Bottle Top Vacuum Filter, 0.22 um, PVDF, Sterile,1/pk, 24/cs
KIF1C (Kinesin-like Protein KIF1C, KIAA0706, LTXS1) (Biotin)